- Home
- ADXN vs OP Comparison
ADXN vs OP Comparison
Compare ADXN & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- OP
- Stock Information
- Founded
- ADXN 2002
- OP 2021
- Country
- ADXN Switzerland
- OP Greece
- Employees
- ADXN N/A
- OP N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- OP
- Sector
- ADXN Health Care
- OP
- Exchange
- ADXN Nasdaq
- OP Nasdaq
- Market Cap
- ADXN 10.1M
- OP 5.3M
- IPO Year
- ADXN N/A
- OP N/A
- Fundamental
- Price
- ADXN $9.38
- OP $1.54
- Analyst Decision
- ADXN Strong Buy
- OP
- Analyst Count
- ADXN 1
- OP 0
- Target Price
- ADXN $30.00
- OP N/A
- AVG Volume (30 Days)
- ADXN 17.4K
- OP 9.4M
- Earning Date
- ADXN 08-11-2025
- OP 08-06-2025
- Dividend Yield
- ADXN N/A
- OP N/A
- EPS Growth
- ADXN N/A
- OP N/A
- EPS
- ADXN 0.10
- OP N/A
- Revenue
- ADXN $278,508.00
- OP $25,702,000.00
- Revenue This Year
- ADXN $86.57
- OP N/A
- Revenue Next Year
- ADXN N/A
- OP N/A
- P/E Ratio
- ADXN $0.75
- OP N/A
- Revenue Growth
- ADXN N/A
- OP 35.58
- 52 Week Low
- ADXN $6.51
- OP $0.63
- 52 Week High
- ADXN $13.27
- OP $3.17
- Technical
- Relative Strength Index (RSI)
- ADXN 58.20
- OP 50.21
- Support Level
- ADXN $8.50
- OP $1.82
- Resistance Level
- ADXN $9.87
- OP $2.30
- Average True Range (ATR)
- ADXN 0.78
- OP 0.54
- MACD
- ADXN 0.05
- OP -0.06
- Stochastic Oscillator
- ADXN 72.46
- OP 32.93
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.